With heart rates that commonly vary from 28 to 280 beats per minute and with notoriously complex patterns, the electrocardiograms (ECG) of horses have long perplexed and concerned vets, horse owners and the horse racing industry. But now a post graduate vet has identified the problem and proposed a solution that has won the inaugural prize for the Creative Application of Technology offered by Innovision Research & Technology plc, the electronics technology solutions provider, in association with the IEE (Institution of Electrical Engineers).
Winner of the Innovision R&T prize, Garry Stanway wants to develop a heart ECG monitor for horses which will be robust enough to withstand the rough and tumble of being attached to such an active animal and with software smart enough to make sense of the extraordinary variations in equine heartbeats. Using his prize – and with some additional support from Innovision R&T – Garry hopes to continue to develop his winning idea at the Veterinary Faculty at Liverpool University, where he qualified as a vet and is currently working with colleagues from Veterinary Anaesthesia, and the University of Manchester where Garry is currently completing a PhD at the Department of Computer Science.
“Through our Creative Application of Technology prize run in association with the IEE, we want to reward new designers, researchers and innovators,” said Marc Borrett, Managing Director of Innovision R&T. “Garry Stanway’s idea is just the sort of thing we want to encourage – through his work with horses he has identified a real world problem, analysed the technical barriers which need to be overcome and developed a plan to provide a solution. We are thoroughly delighted to award him the first-ever Innovision R&T / IEE prize.”
On hearing of his award, Garry Stanway said: “My work with horses requiring anaesthesia for necessary operations alerted me to the fact that the morphology, rate and rhythm of equine ECG traces is so different from humans that diagnostic routines using human ECG analysis software are inadequate and even dangerously misleading. Applying for the Innovision R&T & IEE prize encouraged me to further develop my ideas and winning has helped me to gain additional support from the University of Liverpool Veterinary School and Manchester Innovation. I am now seeking funds to complete this work which could have major benefits for equine medical treatment and even the horse-racing industry.”
About Innovision Research & Technology plc
Founded in 1994, Innovision Research & Technology plc is an electronics solutions provider and a major player in the Radio Frequency Identification (RFID) industry.
Through the creation, development and licensing of technologies, Innovision R&T provides innovative solutions to a wide variety of enterprises, including some of the world's largest companies. With a team of thirty engineers and scientists, and commercial expertise honed in some of industry's most challenging sectors, the Company is able to support the entire development process from conceptual design through to production engineering. Innovision R&T works in close partnership with its customers to drive commercial success and deliver competitive value.
Innovision R&T became a public company on the Alternative Investment Market of the London Stock Exchange in 2001 (Ticker Symbol: INN). Its head office is in Wokingham, Berkshire, UK.
Stephen Fleming, SCHAEL Ltd
11 Byfields Road, Kingsclere, Newbury, RG20 5TG, UK
Tel +44 (0) 1635 299116
Fax +44 (0) 1635 299115
Innovision Research & Technology plc
Ash Court, 23 Rose Street, Wokingham, Berks, RG40 1XS, UK
Tel +44 (0) 118 936 6362
Fax +44 (0) 118 979 1500
Director of Communications, The University of Liverpool
Tel +44 (0) 151 794 6989
Dr Michelle Cooper
Business Development Manager, Manchester Innovation Ltd
Tel +44 (0) 161 606 7200
This press release was distributed by ResponseSource Press Release Wire on behalf of Palam Communications in the following categories: Consumer Technology, Personal Finance, Business & Finance, Computing & Telecoms, for more information visit https://pressreleasewire.responsesource.com/about.